Prospects for the use of Belimumab in lupus nephritisOver the past 50 years the survival rate of patients with systemic
lupus erythematosus (SLE
The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I for the management of
lupus nephritis. It discusses the technology of preparing recommendations by an international
Волчаночный нефрит: современные представления о терапии. (Часть II)The second part of the review presents current data on the treatment strategy for
lupus nephritis Lupus nephritis and thrombotic microangiopathy: A reviewLupus nephritis (LN) is one of the most common organ-specific manifestations of systemic
lupus Обновленные рекомендации EULAR/ERA-EDTA 2019 г. по терапии волчаночного нефрита. Комментарии экспертов. Часть I for the management of
lupus nephritis. It discusses the technology of preparing recommendations by an international
Перспективы применения белимумаба при волчаночном нефритеOver the past 50 years the survival rate of patients with systemic
lupus erythematosus (SLE
Особенности течения и трудности диагностики волчаночной подоцитопатииOne of the reasons for the development of nephrotic syndrome (NS) in patients with systemic
lupus